Long-acting injectable therapy: an emerging paradigm for the treatment of HIV infection

Purpose of review Long-acting formulations of antiretrovirals have the potential to reshape the treatment paradigm for HIV infection. Emerging evidence demonstrates efficacy and safety of two drug regimens for the treatment of HIV infection. This review focuses on recent advances with long-acting cabotegravir and rilpivirine administered intramuscularly every 4 weeks for the treatment of HIV infection in virologically suppressed patients. Recent findings Despite the development of complete, orally administered single tablet regimens with improved efficacy, side effects, tolerability, with an improved drug interaction potential, patients still have challenges adhering to daily oral therapy. Psychological factors including HIV stigma contribute to patient's ability to adhere to treatment. Newer nonoral treatment regimens may improve adherence, patient satisfaction and limit HIV stigma. Summary A two-drug intramuscular regimen of cabotegravir and rilpivirine has advanced through phase 3 clinical development. Results from studies assessing safety, virologic, pharmacologic, and drug interactions have been completed. Larger efficacy studies have demonstrated noninferiority of switching virologically suppressed patients from a three drug daily oral regimen to a two-drug intramuscular regimen administered Q4W with long-term data to 160 weeks demonstrating durability of treatment response.
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: LONG ACTING ART FOR TREATMENT AND PREVENTION: Edited by Martin Markowitz Source Type: research

Related Links:

Publication date: Available online 16 January 2020Source: Biocybernetics and Biomedical EngineeringAuthor(s): Julian Andres Ramirez-Bautista, Jorge Adalberto Huerta-Ruelas, László T. Kóczy, Miklós F. Hatwágner, Silvia L. Chaparro-Cárdenas, Antonio Hernández-ZavalaAbstractLoad distribution analysis on foot surface allows knowing human mechanical behavior and aids the doctor in the detection of gait disorders like, the risk of foot ulcerations, leg discrepancy, and footprint alterations. Plantar pressure data combined with techniques that use integral reasoning produce easy un...
Source: Biocybernetics and Biomedical Engineering - Category: Biomedical Engineering Source Type: research
.
Source: AIDS Care - Category: Infectious Diseases Authors: Source Type: research
On this episode of ASHA Voices, we dive into the research behind hearing loss reversal. While investigating a genetic form of hearing loss affecting transduction, researcher Jeff Holt  found he could successfully reverse hearing loss in mice. How did the researcher test the rodents’ hearing? By unexpectedly playing loud music and looking for a response in the subjects, nicknamed Beethoven mice. “A deaf mouse doesn’t jump at all, no matter how loud a sound you play. But after introducing our gene therapy into the ears of Beethoven mice, we find they jump again,” says Holt. Also on the show, sens...
Source: American Speech-Language-Hearing Association (ASHA) Press Releases - Category: Speech-Language Pathology Authors: Tags: Academia & Research Audiology Health Care Podcast Slider Speech-Language Pathology ASHA Convention audiologist Hearing Assistive Technology hearing loss Source Type: blogs
Nationwide improvements in insurance coverage and access to care seen, even in nonexpansion states
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
This report describes that human immunodeficiency virus partner services for transgender women must address social and structural barriers unique to this population.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: HIV/AIDS Lesbian, Gay, Bisexual, and Transgender (LGBT) Health MMWR Morbidity & Mortality Weekly Report Source Type: news
Doubling the dose of influenza vaccine for pregnant women with HIV moderately improves immunogenicity compared to a single flu shot, but response remains well below that of pregnant women without HIV, a clinical trial shows.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: HIV/AIDS News Source Type: news
[Daily Maverick] You're far more likely to be offered an HIV test at a government health facility than at your GP or workplace clinic.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[The Herald] MANICALAND Province has made strides in the fight against HIV, amid indications the prevalence rate has declined compared to the national rate, a development attributed to awareness and access to treatment.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[FrontPageAfrica] Southeastern Liberia -About 73 representatives of local county authorities, Ministry of Health, County Health Officers; the private sector; faith-based organizations; traditional leaders; civil society groups; human rights groups; community-based organizations, key populations to TB/HIV, women-based groups, persons living with HIV; people who are most vulnerable to and affected by the diseases drawn from three of Liberia's 15 political subdivisions, Sinoe, Rivercess, Grand Gedeh have completed a two-day regional country dialogu
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
We described ART initiation characteristics and the probability of mortality, loss to follow-up (LTFU) and transfer out after 6 months on ART and assessed factors associated with mortality and LTFU. Results: A total of 1847 infants started ART at a median age of 60 days [interquartile range: 29–77] and CD4 percentage (%) of 27% (18%–38%). Across ART initiation calendar periods 2006–2009 to 2013–2017, ART initiation age decreased from 68 (53–81) to 45 days (7–71) (P
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: HIV Reports Source Type: research
More News: HIV AIDS | Infectious Diseases | Psychology | Study | Virology